
Opinion|Videos|January 31, 2025
Overcoming Logistical Hurdles in Bispecific Therapy Implementation
Panelists discuss the most common logistical challenges encountered when implementing bispecific therapies in both academic and community settings.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the most common logistical challenges you encounter when implementing bispecific therapies in both academic and community settings? (Dr Allan)
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy
2
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
3
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
4
Top 5 Myasthenia Gravis Content of 2025
5








































